Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Correction: IL-1α Mediates Innate and Acquired Resistance to Immunotherapy in Melanoma.
Journal: Journal of immunology (Baltimore, Md. : 1950)
Published: December 13, 2023
Improving cancer immunotherapy by targeting IL-1.
Journal: Oncoimmunology
Published: December 03, 2021
IL-1α Mediates Innate and Acquired Resistance to Immunotherapy in Melanoma.
Journal: Journal of immunology (Baltimore, Md. : 1950)
Published: May 08, 2020
Cost-Effectiveness Analysis of Ezetimibe as the Add-on Treatment to Moderate-Dose Rosuvastatin versus High-Dose Rosuvastatin in the Secondary Prevention of Cardiovascular Diseases in China: A Markov Model Analysis.
Journal: Drug design, development and therapy
Published: May 06, 2019
The Role of Anatomic Resection in Pulmonary Metastasectomy.
Journal: The Annals of thoracic surgery
Published: February 01, 2019
Stromal Modulation Reverses Primary Resistance to Immune Checkpoint Blockade in Pancreatic Cancer.
Journal: ACS nano
Published: September 20, 2018
Macrophage depletion through colony stimulating factor 1 receptor pathway blockade overcomes adaptive resistance to anti-VEGF therapy.
Journal: Oncotarget
Published: April 18, 2017
Peptide Vaccine Formulation Controls the Duration of Antigen Presentation and Magnitude of Tumor-Specific CD8+ T Cell Response.
Journal: Journal of immunology (Baltimore, Md. : 1950)
Published: March 31, 2017
Cancer vaccine formulation dictates synergy with CTLA-4 and PD-L1 checkpoint blockade therapy.
Journal: The Journal of clinical investigation
Published: February 08, 2017
Unusual cause of massive hemothorax: spontaneous rupture of nonfunctioning mediastinal paraganglioma.
Journal: Journal of thoracic disease
Published: February 03, 2017
Intratumoral CD40 activation and checkpoint blockade induces T cell-mediated eradication of melanoma in the brain.
Journal: Nature communications
Published: November 10, 2016
Should tumor with direct adjacent lobe invasion (Tdali) be assigned to T2 or T3 in non-small cell lung cancer: a meta-analysis.
Journal: Journal of thoracic disease
Published: September 14, 2016
Last Updated: 09/26/2026